Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis

Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis

ObjectiveTo systematically evaluate the effects of pioglitazone in the treatment of patients with prediabetes or T2DM combined with NAFLD.MethodsThe Cochrane Central Register of Controlled Trials (CENTRAL), Embase, and ClinicalTrials databases were searched until August 2020 for publications written...

Full description

Bibliographic Details
Main Authors: Jingxuan Lian, Jianfang Fu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Endocrinology
Subjects:
NAFLD
type 2 diabetes mellitus
pioglitazone
meta-analysis
prediabetes
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2021.615409/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2021.615409/full

Similar Items